Skip to main content

Day: March 24, 2022

Spectral Announces Fourth Quarter and Fiscal 2021 Results and Corporate Update

TORONTO, March 24, 2022 (GLOBE NEWSWIRE) — Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock, as well as commercializing a new proprietary platform targeting the renal replacement therapy market through its wholly-owned subsidiary Dialco Medical Inc. (“Dialco”), today announced its financial results for the fourth quarter and for the year ended December 31, 2021 and provided a corporate update. Chris Seto, CEO of Spectral Medical, commented, “2021 was a foundational year for Spectral and Dialco as we reported key achievements, both clinically and operationally, despite the headwinds presented by several waves of COVID variants.  While clinical enrollment activity continued to be negatively impacted, the Company responded quickly...

Continue reading

FactSet Reports Results for Second Quarter 2022

Q2 revenues of $431.1 million, up 10.0% from Q2 2021 Organic Q2 ASV plus professional services of $1.7 billion, up 9.4% year over year Operating margin of 28.6% and adjusted operating margin of 33.7% Diluted EPS of $2.84, up 13.6% from the prior year; adjusted diluted EPS of $3.27, a 20.2% increase from the prior year. Completed CUSIP Global Services acquisition on March 1, 2022 for $1.925 billion, financed in part by our investment grade inaugural senior notes offering of $1.0 billion FactSet Investor Day will be held on April 5, 2022 in New York CityNORWALK, Conn., March 24, 2022 (GLOBE NEWSWIRE) — FactSet (“FactSet” or the “Company”) (NYSE:FDS) (NASDAQ:FDS), a global provider of integrated financial information, analytical applications, and industry-leading service, today announced results for its second quarter...

Continue reading

Knight Therapeutics Reports Fourth Quarter and Year-End 2021 Results and Provides 2022 Revenue Guidance

MONTREAL, March 24, 2022 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX: GUD) (“Knight” or “the Company”), a leading Pan-American (ex-US) specialty pharmaceutical company, today reported financial results for its fourth quarter and year ended December 31, 2021. All currency amounts are in thousands except for share and per share amounts. All currencies are Canadian unless otherwise specified. 2021 Highlights FinancialsRevenues were $243,478, an increase of $43,959 or 22% over prior year. Gross margin of $115,412 or 47% compared to $81,690 or 41% in prior year. Adjusted EBITDA1 was $38,005, an increase of $21,168 or 126% over prior year. Net gain on financial assets measured at fair value through profit or loss of $18,944. Net income was $15,675, compared to net income of $31,760 in prior year. Cash inflow from operations...

Continue reading

Real Brands Announces Entry to Medical Psychedelics Market, Partners with Marcu & Arora for Licensure, R&D

Real Brands applying for DEA psychedelics licensure Psychedelics drugs market size is projected to reach $10.75 billion by 2027 Real Brands planning to leverage new clinical research to produce and deliver safe, nature-based psychedelics product formulations that will effectively treat mental health conditionsNorth Providence, RI, March 24, 2022 (GLOBE NEWSWIRE) — Real Brands Inc. (OTCQB: RLBD), a multi-brand owner, formulator, extractor and manufacturer of branded hemp-derived CBD products, is initiating expansion to become a premier provider of medical psychedelics. As Phase 1 of laying the groundwork for entry into the medical psychedelics market, Real Brands has entered a partnership with consulting firm Marcu & Arora to apply for U.S. Drug Enforcement Agency (DEA) licensure for psychedelics, including defining the...

Continue reading

Barrick Announces Sale of Shares of Skeena Resources Ltd

TORONTO, March 24, 2022 (GLOBE NEWSWIRE) — Barrick Gold Corporation (“Barrick”) (NYSE:GOLD) (TSX:ABX) announced today that it has entered into a purchase and sale agreement (the “Purchase Agreement”) dated March 23, 2022 with a Canadian investment dealer (the “Dealer”) pursuant to which Barrick agreed to sell, and the Dealer agreed to purchase, 8,831,250 common shares of Skeena Resources Ltd. (“Skeena”) for resale on a bought deal basis, on and subject to the terms and conditions set forth in the Purchase Agreement (the “Disposition”). The gross consideration for the common shares consists of cash in the aggregate amount of C$132,468,750 (C$15.00 per common share). Immediately prior to the closing of the Disposition, Barrick will have beneficial ownership of, or control and direction over, 8,831,250 common shares of Skeena, representing...

Continue reading

Mata Mata Turtle with Squamous Cell Carcinoma Successfully Treated with Sensus Healthcare’s SRT System by Colorado State University Veterinarian

Joins multiple companion animals and a horse successfully treated with SRT BOCA RATON, Fla. , March 24, 2022 (GLOBE NEWSWIRE) — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that a mata mata turtle has joined the growing list of animal species successfully treated with Sensus Healthcare’s SRT-100 system.  Tiffany Martin, DVM, MS, Assistant Professor, Radiation Oncology at Colorado State University Veterinary Teaching Hospital applied superficial radiation therapy (SRT) to the turtle’s squamous cell carcinoma in June 2021.  The female turtle, which resides at Denver Zoo, showed no signs of the lesion three months after therapy, and continues to be cancer-free...

Continue reading

HCW Biologics to Present at 2022 Virtual Growth Conference Sponsored by the Maxim Group and M-Vest

Founder and CEO, Hing C. Wong, Ph.D., to be guest at “Fireside Chat” MIRAMAR, Fla., March 24, 2022 (GLOBE NEWSWIRE) — HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation and age-related diseases, will participate in Maxim’s 2022 Virtual Growth Conference being held March 28 – 30, 2022. Members of the HCW Biologics’ management team will provide an overview of the Company highlighting the status of its internal pipeline, upcoming milestones for multiple clinical trials for difficult-to-treat cancer indications, and its clinical development strategy to expand to the treatment of other age-related diseases associated with the chronic state of...

Continue reading

Daré Bioscience to Host Full-year 2021 Financial Results and Company Update Conference Call and Webcast on March 31, 2022

SAN DIEGO, March 24, 2022 (GLOBE NEWSWIRE) — Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that it will host a conference call and live webcast at 4:30 p.m. Eastern Time on Thursday, March 31, 2022, to review its financial results for the year ended December 31, 2021 and to provide a Company update. To access the conference call via phone, dial (844) 831-3031 (U.S.) or (443) 637-1284 (international). The conference ID number for the call is 1185595. The live webcast can be accessed under “Presentations, Events & Webcasts” in the Investors section of the Company’s website at http://ir.darebioscience.com. Please log in approximately 5-10 minutes prior to the call to register and to download and install any necessary software. To access the replay, please call (855) 859-2056...

Continue reading

ProStar Announces That One Of America’s Largest Heavy Highway Construction Companies Has Adopted ProStar’s Cloud And Mobile Precision Mapping Solution

GRAND JUNCTION, Colo., March 24, 2022 (GLOBE NEWSWIRE) — ProStar Holdings Inc. (“ProStar®” or “the Company”) (TSXV: MAPS) (OTCQX: MAPPF) (FSE: 5D00), a world leader in Precision Mapping Solutions®, is pleased to announce that Kokosing Construction Company, Inc, one of America’s largest heavy highway construction companies has implemented ProStar’s cloud and mobile solution, PointMan®. “Our focus has always been on placing the best tools and technologies available into our team members’ hands in order to allow everyone on the project site to work more efficiently and safely,” stated Terry Hendershot, General Manager Underground Utilities at Kokosing Construction. “Not knowing the location of underground utilities on a construction project exposes us to major risks and liabilities that can be costly. PointMan helps us to achieve...

Continue reading

Industry leaders to speak at Wood Mackenzie’s European Power & Renewables Conference

Join executives from EDF Energy, Renewable Energy Institute and Société Générale as Europe’s energy sector gears up for critical transformation LONDON/HOUSTON/SINGAPORE, March 24, 2022 (GLOBE NEWSWIRE) — This year looks set to define the European power and renewables sector: an energy market that faces dangerously volatile energy prices, fears of ‘greenflation’ and rising geopolitical risks. As European and national energy regulators, utilities, solar and wind developers and institutional and private investors determine how the renewables sector can evolve over the next decade to meet ambitious emission reduction targets, Wood Mackenzie will host European energy industry leaders at its European Power & Renewables Conference on April 25-26. The hybrid in-person and virtual conference will bring together CEOs, policymakers,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.